Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters
Schwab N, Schneider-Hohendorf T, Hoyt T, Gross CC, Meuth SG, Klotz L, Foley JF, Wiendl H
Research article (journal) | Peer reviewedDetails about the publication
Volume: 24
Issue: 5
Page range: 563-573
Status: Published
Release year: 2017
Language in which the publication is written: English
Link to the full text: http://www.ncbi.nlm.nih.gov/pubmed/28847222
Authors from the University of Münster
| Groß, Catharina | Department for Neurology |
| Klotz, Luisa Hildegard | Department for Neurology |
| Meuth, Sven | Department for Neurology |
| Schneider-Hohendorf, Tilman | Department for Neurology |
| Schwab, Nicholas Christopher | Department for Neurology |
| Wiendl, Heinz Siegfried | Department for Neurology |